GLP-1s: Gut issues & autoimmunity?

Hong Kong Yanpep International
The anti-inflammatory mechanism of GLP-1 affecting multiple autoimmune conditions simultaneously is the clinical picture that makes the most sense - the pathway modulation is not condition-specific and can affect several inflammatory processes in parallel. Multi-condition improvement is one of the better arguments for treating the metabolic root rather than each condition separately.
 
The post-norovirus gut inflammation causing temporary lactose intolerance and IBS-like symptoms is a real and recognized phenomenon - the intestinal lining takes time to restore the enzyme density and microbiome balance after a significant viral insult. Running GLP-1 during that recovery phase adds slowed motility on top of gut lining that's already fragile, which can amplify both the constipation and the sensitivity responses.
 
the Hashimoto's and GLP-1 combination producing a lower levothyroxine dose requirement is the specific autoimmune overlap that comes up most consistently in these threads - the inflammation reduction from GLP-1 appears to improve thyroid function enough in some people with autoimmune thyroid disease that the replacement dose needs recalibration. tracking labs more frequently after starting GLP-1 is worth raising with your endocrinologist if you are on levothyroxine
 
Back
Top